Hydrogel particles as feeder cells and as synthetic antigen presenting cells
The present disclosure provides feeder hydrogel particles that can function to support the growth, proliferation, and/or activation of a target cell in culture. The present disclosure also provides methods of culturing target cells with feeder hydrogel particles.
1. A magnetic capture hydrogel particle, comprising:
a) a hydrogel matrix, said hydrogel matrix comprising a magnetic material embedded and/or encapsulated therein, such that the hydrogel particle is capable of being attracted to or repelled by a magnetic field; and
b) a ligand capable of binding the hydrogel matrix to a capture target molecule,
wherein the magnetic capture hydrogel particle is spherical and has a diameter of between about 2 μm and about 5 μm.
2. The magnetic capture hydrogel particle of claim 1 , wherein the hydrogel matrix comprises a polymerized monomer and a bifunctional monomer.
3. The magnetic capture hydrogel particle of claim 2 , wherein the monomer comprises acrylate or acrylamide.
4. The magnetic capture hydrogel particle of claim 2 , wherein the monomer is selected from the group consisting of hydroxyethyl methacrylate, ethyl methacrylate, 2-hydroxyethyl methacrylate (HEMA), propylene glycol methacrylate, acrylamide, N-vinylpyrrolidone (NVP), methyl methacrylate, glycidyl methacrylate, glycerol methacrylate (GMA), glycol methacrylate, ethylene glycol, fumaric acid, 2-hydroxyethyl methacrylate, hydroxyethoxyethyl methacrylate, hydroxydiethoxyethyl methacrylate, methoxyethyl methacrylate, methoxyethoxyethyl methacrylate, methoxydiethoxyethyl methacrylate, poly (ethylene glycol) methacrylate, methoxy-poly (ethylene glycol) methacrylate, methacrylic acid, sodium methacrylate, glycerol methacrylate, hydroxypropyl methacrylate, hydroxybutyl methacrylate, phenyl acrylate, phenyl methacrylate, benzyl acrylate, benzyl methacrylate, 2-phenylethyl acrylate, 2-phenylethyl methacrylate, 2-phenoxyethyl acrylate, 2-phenoxyethyl methacrylate, phenylthioethyl acrylate, phenylthioethyl methacrylate, 2,4,6-tribromophenyl acrylate, 2,4,6-tribromophenyl methacrylate, pentabromophenyl acrylate, pentabromophenyl methacrylate, pentachlorophenyl acrylate, pentachlorophenyl methacrylate, 2,3-dibromopropyl acrylate, 2,3-dibromopropyl methacrylate, 2-naphthyl acrylate, 2-naphthyl methacrylate, 4-methoxybenzyl acrylate, 4-methoxybenzyl methacrylate, 2-benzyloxyethyl acrylate, 2-benzyloxyethyl methacrylate, 4-chlorophenoxyethyl acrylate, 4-chlorophenoxyethyl methacrylate, 2-phenoxyethoxyethyl acrylate, 2-phenoxyethoxyethyl methacrylate, N-phenyl acrylamide, N-phenyl methacrylamide, N-benzyl acrylamide, N-benzyl methacrylamide, N,N-dibenzyl acrylamide, N,N-dibenzyl methacrylamide, N-diphenylmethyl acrylamide N-(4-methylphenyl) methyl acrylamide, N-1-naphthyl acrylamide, N-4-nitrophenyl acrylamide, N-(2-phenylethyl) acrylamide, N-triphenylmethyl acrylamide, N-(4-hydroxyphenyl) acrylamide, N,N-methylphenyl acrylamide, N,N-phenyl phenylethyl acrylamide, N-diphenylmethyl methacrylamide, N-(4-methyl phenyl) methyl methacrylamide, N-1-naphthyl methacrylamide, N-4-nitrophenyl methacrylamide, N-(2-phenylethyl) methacrylamide, N-triphenylmethyl methacrylamide, N-(4-hydroxyphenyl) methacrylamide, N,N-methylphenyl methacrylamide, N,N′-phenyl phenylethyl methacrylamide, N-vinylcarbazole, 4-vinylpyridine, 2-vinylpyridine, and a combination thereof.
5. The magnetic capture hydrogel particle of claim 2 , wherein the monomer is selected from the group consisting of N,N′-methylenebisacrylamide, N,N′methylene bismethacrylamide, N,N′-ethylene bisacrylamide, N,N′-ethylene bismethacrylamide, N,N′propylenebisacrylamide, and N,N′-(1,2-dihydroxyethylene) bisacrylamide.
6. The magnetic capture hydrogel particle of claim 1 , wherein the capture target molecule is on a cell selected from the group consisting of a B cell, a T cell, a natural killer cell, a lymphokine-activated killer cell, a monocyte, a macrophage, a neutrophil, a granulocyte, a mast cell, a platelet, a Langerhans cell, a stem cell, a dendritic cell, a peripheral blood mononuclear cell, a tumor infiltrating (TIL) cell, gene modified immune cells including hybridomas, drug modified immune cells, and combinations thereof.
7. The magnetic capture hydrogel particle of claim 1 , wherein the capture target molecule is a biomarker.
8. The magnetic capture hydrogel particle of claim 1 , wherein the capture target molecule is selected from the group consisting of CD2, CD3, CD4, CD8, CD19, CD20, CD25, CD27, CD28, CD30, CD40, CD40L, CD45RO, CD62L, CD69, CD62L, CD80, CD84, CD86, CD95, CD122, CD127, CD134, CD137, CD137L, CD150, CD154, CD226, CD229, CD244, CD270, CD278, CD319, CD352, CD355, CD357, membrane-bound IL-15, HLA-DR, CCR6, and FOXP3.
9. The magnetic capture hydrogel particle of claim 1 , wherein the hydrogel matrix is degradable.
10. The magnetic capture hydrogel particle of claim 9 , wherein the degradable matrix includes at least one disulfide crosslink.
11. The magnetic capture hydrogel particle of claim 1 , wherein the ligand is an antibody or antigen-binding fragment thereof.
12. A method for separating a target molecule from an aqueous mixture, the method comprising:
a) incubating an aqueous mixture comprising a target molecule and a magnetic capture hydrogel particle, thereby producing a target molecule-bound magnetic capture hydrogel particle, wherein the magnetic capture hydrogel particle comprises:
i) a hydrogel matrix comprising a magnetic material embedded and/or encapsulated therein, such that the hydrogel particle is capable of being attracted to or repelled by a magnetic field; and
ii) a ligand capable of binding the hydrogel matrix to the target molecule, wherein the magnetic capture hydrogel particle is spherical and has a diameter of between about 2 μm and about 5 μm;
b) applying a magnetic field to the incubated aqueous mixture to isolate the target molecule-bound magnetic capture hydrogel particle from the aqueous mixture; and
c) retrieving the isolated target molecule-bound magnetic capture hydrogel particle.
13. The method of claim 12 , comprising step:
d) separating, the target molecule from the magnetic capture hydrogel particle.
14. The method of claim 13 , wherein the separating comprises dissolving the magnetic capture hydrogel particle.
15. The method of claim 13 , wherein the dissolving the magnetic capture hydrogel particle comprises exposing the magnetic capture hydrogel particle to a disulfide reducing agent.
16. The method of claim 13 , wherein the separating comprises cleaving the target molecule from the magnetic capture hydrogel particle.
17. A method for separating a target cell from an aqueous mixture, the method comprising:
a) incubating an aqueous mixture comprising a target cell and a magnetic capture hydrogel particle, thereby producing a target cell-bound magnetic capture hydrogel particle, wherein the magnetic capture hydrogel particle comprises:
i) a hydrogel matrix comprising a magnetic material embedded and/or encapsulated therein, such that the magnetic capture hydrogel particle is capable of being attracted to or repelled by a magnetic field; and
ii) a ligand capable of binding the hydrogel matrix to the target cell, wherein the magnetic capture hydrogel particle is spherical and has a diameter of between about 2 μm and about 5 μm;
b) applying a magnetic field to the incubated aqueous mixture to isolate the target cell-bound magnetic capture hydrogel particle from the aqueous mixture; and
c) retrieving the isolated target cell-bound magnetic capture hydrogel particle.